Holen Sie sich die Stockscreener-App
9.13
8.56%
0.72
Handel nachbörslich:
8.87
-0.26
-2.85%
Arcturus Therapeutics Holdings Inc Aktie (ARCT) Neueste Nachrichten
Arcturus Therapeutics Holdings Inc (ARCT) Q1 2026 Earnings Repor - GuruFocus
MSN Money - MSN
ARCT Stock Price, Quote & Chart | ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) - ChartMill
Arcturus Therapeutics (ARCT) Projected to Post Earnings on Thursday - MarketBeat
Arcturus Therapeutics (NASDAQ:ARCT) Shares Cross Below 200 Day Moving AverageTime to Sell? - MarketBeat
Arcturus Therapeutics Holdings (ARCT) price target decreased by 27.17% to 25.78 - MSN
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May - PharmiWeb.com
Arcturus plans after-hours results and a 4:30 p.m. ET call May 7 - Stock Titan
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026 - Business Wire
How Arcturus Therapeutics Holdings Inc. (ARCT) Affects Rotational Strategy Timing - Stock Traders Daily
ARCT Price Today: Arcturus Therapeutics Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Arcturus (NASDAQ: ARCT) schedules 2026 virtual meeting on pay, board and auditor - Stock Titan
Diversify Advisory Services LLC Sells 115,500 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Navigating a 170% Potential Upside with Innovative Biotechnology - DirectorsTalk Interviews
(ARCT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Published on: 2026-04-10 06:58:22 - baoquankhu1.vn
Is Arc Tx (ARCT) Stock Good for Portfolio | Price at $8.40, Down 1.22%Breakout Confirmation - Cổng thông tin điện tử tỉnh Lào Cai
Should I Buy Arc Tx (ARCT) Stock Now | Price at $8.44, Up 5.14%Trending Buy Opportunities - Xã Châu Thành
HC Wainwright & Co. Downgrades Arcturus Therapeutics Holdings (ARCT) - MSN
Responsive Playbooks and the ARCT Inflection - Stock Traders Daily
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2025 earnings call transcript - MSN
Hennion & Walsh Asset Management Inc. Purchases 161,910 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - marketbeat.com
Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a 196.82% Potential Upside with Cutting-Edge RNA Therapies - DirectorsTalk Interviews
ARCT SEC FilingsArcturus Therape 10-K, 10-Q, 8-K Forms - Stock Titan
Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below 200 Day Moving AverageShould You Sell? - MarketBeat
Arcturus Therapeutics features Chief Medical Officer in The Bonnell Foundation podcast discussion - Traders Union
BTIG Maintains Arcturus Therapeutics Holdings (ARCT) Buy Recommendation - MSN
Cathie Wood’s ARK sells Nvidia stock, buys Arcturus Therapeutics By Investing.com - Investing.com South Africa
Cathie Wood’s ARK sells Nvidia stock, buys Arcturus Therapeutics - Investing.com
ARCT.O - Reuters
Roth MKM Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Vanguard disaggregates holdings; reports 0 shares — Arcturus (ARCT) - Stock Titan
New Highs: Is Arcturus Therapeutics Holdings Inc forming a breakout pattern2026 Historical Comparison & Accurate Buy Signal Notifications - baoquankhu1.vn
Aug Setups: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesMarket Activity Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Understanding the Setup: (ARCT) and Scalable Risk - Stock Traders Daily
Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf - MarketBeat
Arcturus Therapeutics at the 38th Annual Roth Conference: Strategic Shift to Rare Diseases - Investing.com Canada
These Are the Only 3 Stocks That Cathie Wood Bought Last Week - The Motley Fool
Arcturus Therapeutics stock plunges 50% after weak cystic fibrosis trial data - MSN
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga
Arcturus Therapeutics (NASDAQ:ARCT) Stock Rating Upgraded by B. Riley Financial - marketbeat.com
This BP Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Friday - Benzinga
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Average Recommendation of "Moderate Buy" from Analysts - marketbeat.com
Cathie Wood’s ARK adds 10x Genomics stock, trims Arcturus By Investing.com - Investing.com South Africa
This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday - Benzinga
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - benzinga.com
This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
B Riley Securities initiates coverage of Arcturus Therapeutics Holdings (ARCT) with buy recommendation - MSN
1.77%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):